Skip to main content

Table 2 Striatal uptake on radiotracer imaging in our patient compared with mean uptake in normal databases

From: Dystonia-deafness syndrome caused by ACTB p.Arg183Trp heterozygosity shows striatal dopaminergic dysfunction and response to pallidal stimulation

Brain radiotracer modality

Putamen

Caudate nucleus

Right

Left

Right

Left

%

SD

%

SD

%

SD

%

SD

DAT-SPECT

72

− 2.6

74

− 2.3

80

− 1.7

82

− 1.5

Epidepride-SPECT

65

− 4.9

76

− 3.4

81

− 2.7

86

− 1.9

FDG-PET

 

− 4.2

 

− 3.6

 

− 3.2

 

− 3.7

  1. Numbers represent percent of uptake (%) and standard deviation (SD) compared with mean uptake in normal databases for the three radiotracers. DAT (dopamine transporter)-SPECT (123I-ioflupane single-photon emission computed tomography) uptake was compared with a commercial database (DaTQuant, GE) that included an extrapolation for age. SPECT with 123I-epidepride (which binds to dopamine type 2-receptors) was compared with a non-age-matched database (older patient group, because this modality is very rarely used in the patient’s age group; local data, Hermes BRASS). 18Fluoro-Deoxy-Glucose (FDG)–PET was compared with an age-matched database (local data, PMOD PNEURO)